Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Pantoprazole Sodium

Pantoprazole Sodium

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)40790
US makers7 labelers
Packages15
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.683$1.37$2.05$2.73May 2025Feb 2026Mar 2026
$2.374
Latest avg · Mar 18, 2026
+28%
Since May 21, 2025
7
Active US suppliers
53%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.8K3.7K5.5K7.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.9K
Rx · 2026 Q1
8.9K
Units dispensed
-33%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown5SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown1SUPPLYING
Civica, Inc.unknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 5, 2021
    RECALLRecall (Class III): Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. …

    Failed Impurity/Degradation Specifications — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide